Penka S. Petrova

MANF: A New Mesencephalic, Astrocyte-Derived Neurotrophic Factor with Selectivity for Dopaminergic Neurons

Penka S. Petrova, Andrei A. Raibekas, Jonathan Pevsner et al. · Journal of Molecular Neuroscience · 2003 · 354 citations

Medicine, Neurobiology, Neuroscience +12

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

Penka S. Petrova, Natasja Nielsen Viller, Mark Wong et al. · Clinical Cancer Research · 2016 · 276 citations

Life Sciences, Immunology, Oncology +17

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin et al. · Clinical Cancer Research · 2021 · 196 citations · Full text

Medicine, Hematology, Pharmacology +17

Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study

Christiane Querfeld, John A. Thompson, Matthew H. Taylor et al. · The Lancet Haematology · 2021 · 75 citations

Life Sciences, Immunology, Oncology +14

TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets

Gloria H. Y. Lin, Vien Chai, Vivian Lee et al. · PLoS ONE · 2017 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17